Colorectal Cancer Screening: Which Test Is Right for You?

When Maria turned 45, her doctor told her it was time to start screening for colorectal cancer. But instead of simply scheduling a colonoscopy like her parents’ generation did, Maria faced a confusing array of choices: colonoscopy, Cologuard stool test, FIT tests, CT scans, and even a newly approved blood test called Shield. Each came with different pros and cons, different levels of accuracy, and different recommendations from her doctor. Like millions of Americans reaching screening age, Maria wondered: which test is actually right for me?

The answer isn’t one-size-fits-all, and that’s actually good news. The American Cancer Society 2018 guideline for colorectal cancer screening recommends that average-risk adults aged 45 years and older undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) exam, based on personal preferences and test availability American Cancer Society. Having multiple effective screening options means more people can find a method they’re comfortable with, which ultimately saves lives. Colorectal cancer is highly preventable and treatable when caught early, but only if people actually get screened.

Why Screening Matters So Much

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States, and it’s the second leading cause of cancer deaths. But here’s the crucial fact: it doesn’t have to be. Unlike many cancers, colorectal cancer is largely preventable through screening. Most colorectal cancers start as small growths called polyps that form on the inner lining of the colon or rectum. These polyps usually take 10 to 15 years to turn into cancer, creating a huge window of opportunity to find and remove them before they ever become dangerous.

When colorectal cancer is caught in its earliest stage—before it has spread beyond the colon or rectum—the five-year survival rate is about 90%. Compare that to cancers caught after they’ve spread to distant organs, where survival rates drop dramatically. The difference between life and death often comes down to whether someone got screened at the right time with the right test. Unfortunately, approximately 30% of eligible people in the United States still have not been screened for colorectal cancer, often because they’re confused about which test to choose, worried about the preparation, or simply putting it off.

Who Should Get Screened And When

Current guidelines recommend that most adults start colorectal cancer screening at age 45, a change from the previous recommendation of age 50. This shift happened because colorectal cancer rates have been rising dramatically in younger adults over the past two decades. One in five colorectal cancer diagnoses now occurs in people under age 55, nearly double the rate from 1995. Starting screening at 45 gives doctors a chance to catch cancer or precancerous polyps in people who might have developed them in their late 40s.

For people at average risk—meaning no personal history of colorectal polyps or cancer, no family history of the disease, no inflammatory bowel disease like Crohn’s or ulcerative colitis, and no inherited genetic syndromes—screening should continue regularly until age 75. Between ages 76 and 85, the decision to continue screening should be made individually with your doctor based on your overall health, life expectancy, and whether you’ve been screened regularly before. After age 85, most people no longer need screening.

However, people at higher risk need different screening schedules. If you have a first-degree relative—parent, sibling, or child—who had colorectal cancer or advanced polyps before age 60, or if you have two or more first-degree relatives with the disease at any age, you should start screening earlier, typically at age 40 or ten years before the youngest affected relative was diagnosed, whichever comes first. People with inflammatory bowel disease, hereditary cancer syndromes like Lynch syndrome or familial adenomatous polyposis, or a personal history of colorectal cancer need even more intensive surveillance starting at younger ages. These high-risk individuals should always discuss their screening plan with a gastroenterologist.

Colonoscopy: The Gold Standard

Colonoscopy is the gold standard of screening tests, and identifies approximately 95% of colorectal cancers Harvard Health. During a colonoscopy, a gastroenterologist uses a flexible tube with a camera on the end—called a colonoscope—to examine your entire colon and rectum. The procedure offers a unique advantage that no other test can match: it’s both diagnostic and therapeutic. If the doctor finds polyps during the examination, they can remove them immediately during the same procedure, preventing those polyps from ever becoming cancer. This makes colonoscopy not just a screening test but also a cancer prevention tool.

The procedure takes place in an outpatient facility or hospital, and most patients receive sedation to keep them comfortable. You won’t be under general anesthesia, but you’ll likely sleep through the procedure and won’t remember it. The examination itself usually takes 30 to 60 minutes. If you get a normal result with no polyps found, you typically don’t need another colonoscopy for ten years—the longest interval of any screening test. This convenience factor appeals to many people who want to “get it done” and not think about screening again for a decade.

The downsides of colonoscopy are well-known. The preparation is the part most people dread—you must follow a clear liquid diet the day before and drink a large volume of laxative solution to completely empty your colon. This prep can be uncomfortable and inconvenient, keeping you close to a bathroom for several hours. You’ll need someone to drive you home after the procedure because of the sedation. The test also carries small risks: about 1 in 1,000 colonoscopies results in bleeding or a tear in the colon wall, risks that increase slightly with age. However, serious complications are rare, and for most people, the benefits far outweigh these risks.

It’s important to note that colonoscopy quality depends significantly on the skill of the doctor performing it. Studies show that adenoma detection rates—the percentage of colonoscopies where at least one adenoma is found—vary dramatically among doctors, from as low as 5% to as high as 50%. This variation matters because doctors who find more adenomas are better at preventing colorectal cancer in their patients. When choosing where to get your colonoscopy, ask about the facility’s adenoma detection rates and the experience of their gastroenterologists.

Cologuard: At-Home Stool Testing

Cologuard represents a newer type of stool test that’s gained significant popularity since its approval in 2014. Unlike simple tests that just check for blood in stool, Cologuard uses advanced stool technology to detect DNA and blood cells released from altered cells. It can detect both precancer and cancer Cologuard. The test looks for 10 different DNA markers associated with colorectal cancer and also checks for microscopic blood, giving it better accuracy than older stool tests.

Cologuard found 92% of all colon cancers (and 94% of all stage I & II cancers) in a clinical study of 10,000 participants, ages 50-84 years old, who are of average risk for colorectal cancer Cologuard. This high detection rate for cancer makes it an effective screening tool. The test also detects about 42% of precancerous polyps, though this is much lower than colonoscopy’s near 95% detection rate. Still, finding even some polyps is better than finding none, and Cologuard’s convenience helps get people screened who might otherwise avoid testing altogether.

Using Cologuard is straightforward. Your doctor prescribes the test, and a kit arrives at your home. You collect a stool sample in the privacy of your bathroom following the included instructions, then mail the kit back to the laboratory. Results typically arrive within two weeks. If the test is negative, you repeat it every three years. If it’s positive, you need a follow-up colonoscopy to determine whether you actually have cancer or polyps. This follow-up requirement is important because false positives can occur—about 13% of positive Cologuard results turn out to be false alarms, meaning the test suggested cancer when none was present.

Cologuard is an appropriate alternative for people who are at a low risk for developing colorectal cancer but who may be reluctant to go through the bowel preparation required with a colonoscopy City of Hope. However, the test isn’t appropriate for everyone. People at high risk for colorectal cancer—those with inflammatory bowel disease, a personal or family history of colorectal cancer or polyps, or genetic conditions—should not use Cologuard. These individuals need colonoscopy’s higher detection capability and the ability to remove polyps immediately. Additionally, if you’re going to need a colonoscopy anyway for a positive Cologuard result, some people prefer to skip the stool test and go straight to colonoscopy.

FIT Tests: Simple Blood Detection

Fecal immunochemical tests (FIT) represent another stool-based screening option. FIT tests look for hidden blood in stool, which can indicate polyps or cancer. These tests are simpler and less expensive than Cologuard—they detect blood but don’t analyze DNA. You collect a small stool sample at home using a special card or tube, then mail it to a laboratory for analysis. FIT tests must be done every year, unlike Cologuard’s three-year interval or colonoscopy’s ten-year interval.

The main advantage of FIT tests is their simplicity and low cost. Many insurance plans cover them with no out-of-pocket cost. They don’t require any dietary restrictions or medication changes before testing. The main disadvantage is that they’re less sensitive than Cologuard or colonoscopy. FIT tests detect about 73-79% of colorectal cancers and about 24% of advanced polyps. They also have a higher rate of false positives—as many as 30% of positive FIT tests turn out to be false alarms from hemorrhoids, minor inflammation, or other benign causes. Still, annual FIT testing is proven to reduce colorectal cancer deaths, making it a reasonable choice for people who won’t or can’t undergo colonoscopy or use other tests.

Shield Blood Test: The Newest Option

In July 2024, the FDA approved Shield, the first blood test for colorectal cancer screening. This represents an exciting development because a simple blood draw at your doctor’s office is much more convenient than preparing for a colonoscopy or collecting stool samples. The approval was based on findings from a study that involved nearly 8,000 people, in which the test detected colorectal cancers in more than 83% of the participants found to have colorectal cancer on colonoscopy National Cancer Institute. The test works by detecting cancer DNA fragments circulating in the bloodstream.

However, Shield has significant limitations that make many experts hesitant to recommend it. Its sensitivity for detecting precancerous growths in the colon was much lower, only about 13% National Cancer Institute. This is a critical weakness because the whole point of screening is to catch polyps before they become cancer. Shield also missed 35% of stage 1 colorectal cancers in the approval study, meaning more than one in three early cancers went undetected. While the test shows promise and may improve over time, most gastroenterologists currently recommend Cologuard or colonoscopy over Shield for people who can access those options.

Making Your Decision

Choosing the right screening test depends on several factors: your personal risk level, your preferences about test invasiveness and preparation, how often you’re willing to be tested, and what your insurance covers. For average-risk adults comfortable with preparation and sedation, colonoscopy remains the best choice because of its high accuracy, ability to remove polyps immediately, and long interval between tests. For people who strongly prefer an at-home option, Cologuard offers good cancer detection with reasonable polyp detection, though it requires repeat testing every three years.

FIT tests work well for people who want the simplest, cheapest option and don’t mind testing every year. Shield blood tests may appeal to people who refuse all other options, though its limited accuracy for polyps and early cancer makes it less ideal. The most important decision is to get screened with some test rather than not getting screened at all. Any of these tests is better than no test, and all have been proven to save lives when used appropriately.

Talk to your doctor about which test makes sense for your situation. Be honest about barriers that might prevent you from completing a test—if you know you won’t do the colonoscopy prep, tell your doctor so they can help you find an alternative you’ll actually use. Insurance coverage varies, so check what your plan covers before deciding. Remember that positive results from stool tests or blood tests always require follow-up colonoscopy, so factor that into your decision. Whatever test you choose, the key is starting screening at age 45 (or earlier if you’re high risk) and continuing it regularly according to the recommended schedule for that particular test.

Frequently Asked Questions

Q1: If I do Cologuard and it’s positive, do I really need to follow up with colonoscopy? Yes, absolutely. A positive Cologuard, FIT, or Shield test means something triggered the test—blood or abnormal DNA in your stool or bloodstream—but it doesn’t confirm cancer or identify polyps that need removal. Only colonoscopy can do that. About 13% of positive Cologuard results are false positives (no cancer or polyps found), but you won’t know unless you get the colonoscopy. Plus, if you do have polyps, the colonoscopy removes them, preventing cancer.

Q2: Can I choose colonoscopy once every ten years instead of doing Cologuard every three years? For average-risk adults, yes. Many people prefer colonoscopy’s longer interval despite the more intensive preparation. If you’re comfortable with colonoscopy and don’t have medical conditions that make sedation risky, going straight to colonoscopy every 10 years (if normal) is perfectly reasonable and avoids the need for repeated stool testing. Discuss with your doctor to make sure colonoscopy is appropriate for you.

Q3: My doctor recommended colonoscopy but I’m really nervous about the sedation. What are my options? First, discuss your concerns with your doctor—modern sedation is very safe and most people don’t remember the procedure at all. If you still prefer to avoid it, Cologuard or annual FIT tests are reasonable alternatives for average-risk individuals. However, understand that these tests are less accurate and require follow-up colonoscopy if positive anyway. Some facilities also offer colonoscopy with lighter sedation or even without sedation, though this is less common.

Q4: Is the Shield blood test as good as colonoscopy or Cologuard? No. Shield detected 83% of cancers but only 13% of precancerous polyps, and it missed 35% of early-stage cancers. Colonoscopy detects over 95% of cancers and polyps. Cologuard detects 92% of cancers and 42% of polyps. Shield may be better than nothing for people who refuse all other tests, but most experts don’t recommend it as a first choice when better options are available.

Q5: I’m 50 and had a colonoscopy at 45 with no polyps. Do I really need to wait ten years for my next one? Generally yes, if you’re at average risk and the colonoscopy was high-quality (complete examination with good bowel preparation). Ten years is the standard interval after a normal colonoscopy for average-risk individuals. However, if you have risk factors you didn’t mention (family history, inflammatory bowel disease) or if polyps were found and removed, your interval might be shorter. Follow your gastroenterologist’s specific recommendation based on your results.

Disclaimer

This article adapts publicly available information from reputable medical organizations and research. This content is for informational and educational purposes only and does not constitute medical advice. ObserverVoice.com is a news and information platform — not a healthcare provider. Colorectal cancer screening recommendations vary based on individual risk factors, medical history, and personal circumstances. Please consult with a qualified healthcare professional to determine the best screening strategy for your specific situation.

References

1. American Cancer Society. Colorectal Cancer Screening Guidelines. https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines/colorectal-cancer-screening-guidelines.html
2. U.S. Preventive Services Task Force. Colorectal Cancer: Screening Recommendation. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
3. National Cancer Institute. Shield Blood Test Approved for Colorectal Cancer Screening. https://www.cancer.gov/news-events/cancer-currents-blog/2024/shield-blood-test-colorectal-cancer-screening
4. Harvard Health Publishing. Colon cancer screening decisions: What’s the best option and when? https://www.health.harvard.edu/blog/colon-cancer-screening-decisions-whats-the-best-option-and-when-202206152762
5. American Cancer Society. Colorectal Cancer Screening Tests. https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html
6. Memorial Sloan Kettering Cancer Center. Is Shield a Good Colorectal Cancer Screening Blood Test? https://www.mskcc.org/news/is-shield-good-colorectal-cancer-screening-blood-test